Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience
The coronavirus pandemic showed not only an increase in levels of excess morbidity and mortality in the acute phase, but also persisting symptoms 4 weeks after the onset of the disease. A review of international studies on the prevalence and diversity of the manifestations of postcoid syndrome is pr...
Saved in:
| Main Authors: | V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasil'eva, E. P. Batrakova, N. V. Lobova, E. E. Bykova, M. M. Khachuroeva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
by: V. I. Podzolkov, et al.
Published: (2023-01-01) -
Postural Orthostatic Tachycardia Syndrome as a Manifestation of Post-COVID-19 Syndrome
by: E. L. Trisvetova
Published: (2022-05-01) -
Comparative cohort study of post-acute COVID-19 infection with a nested, randomized controlled trial of ivabradine for those with postural orthostatic tachycardia syndrome (the COVIVA study)
by: David Saunders, et al.
Published: (2025-07-01) -
Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19
by: V. I. Podzolkov, et al.
Published: (2022-08-01) -
Pediatric postural orthostatic tachycardia syndrome: From mechanisms to individualized management
by: Wenrui Xu, et al.
Published: (2024-12-01)